Vitranu is developing a Tunable Extended Release Capsule (TERCâ„¢) for sustained delivery of therapeutics to the eye via intravitreal injection. TERCâ„¢ is manufactured with biodegradable polymers using novel electrospinning technology to produce a double-walled, tunable capsule that can be filled with unaltered biologic or small molecule therapeutics. By modifying the electrospinning process parameters, capsules can be made with defined pore sizes and "tuned" to deliver the payload with the desired drug elution profile. This patented and unique approach provides a platform technology to fulfill the unmet need of sustained, controllable ophthalmic drug delivery.
| Website | https://www.vitranu.com |
| Employees | 5 (1 on RocketReach) |
| Founded | 2020 |
| Address | 7720 Rivers Edge Dr Suite 101, Columbus, Ohio 43235, US |
| Industry | Biotechnology |
| Keywords | Ophthalmic Drug Delivery, Drug Delivery, Sustained Release, Ocular Drug Delivery, Biodegradable Polymers, Eye Medication, Controlled Release, Ophthalmology, Electrospinning, Therapeutics, Capsule Technology, Therapeutic Drug Delivery, Pharmaceutical Technology, Biocompatible Materials, Biomedical Engineering, Nanotechnology, Polymer Science, Medical Devices |
| Competitors | DataRobot, H2O.ai, Alteryx, SAS, Altair RapidMiner, IBM, Microsoft, Google, Amazon, Tableau +47 more (view full list) |
Looking for a particular Vitranu employee's phone or email?
Brian Levy is the CEO of Vitranu.
1 people are employed at Vitranu.
Vitranu is based in Columbus, Ohio.